Skip to Content

Johnson & Johnson JNJ

Morningstar Rating
$159.84 −2.28 (1.41%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

JNJ is trading at a 3% discount.
Price
$159.84
Fair Value
$382.00
Uncertainty
Low
1-Star Price
$212.00
5-Star Price
$573.60
Economic Moat
Hmpk
Capital Allocation
Yxvkbzhc

Bulls Say, Bears Say

Bulls

The majority of J&J's near-term patent losses are for products that are hard to manufacture, which should reduce the intensity of generic competition.

Bears

J&J's late-stage drug pipeline is relatively weak for the size of the company, which could create long-term headwinds for growth.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if JNJ is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$162.12
Day Range
$158.27161.61
52-Week Range
$144.95175.97
Bid/Ask
$159.70 / $161.70
Market Cap
$385.02 Bil
Volume/Avg
8.5 Mil / 7.2 Mil

Key Statistics

Price/Earnings (Normalized)
15.32
Price/Sales
4.81
Dividend Yield (Trailing)
2.98%
Dividend Yield (Forward)
2.98%
Total Yield
3.19%

Company Profile

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Value
Total Number of Employees
134,400

Competitors

Valuation

Metric
JNJ
LLY
MRK
Price/Earnings (Normalized)
15.3294.4382.69
Price/Book Value
5.5969.838.36
Price/Sales
4.8120.975.26
Price/Cash Flow
20.1898.1020.77
Price/Earnings
JNJ
LLY
MRK

Financial Strength

Metric
JNJ
LLY
MRK
Quick Ratio
0.910.520.68
Current Ratio
1.160.941.25
Interest Coverage
18.8814.132.33
Quick Ratio
JNJ
LLY
MRK

Profitability

Metric
JNJ
LLY
MRK
Return on Assets (Normalized)
13.98%10.22%3.59%
Return on Equity (Normalized)
35.02%52.03%9.12%
Return on Invested Capital (Normalized)
22.24%19.27%5.88%
Return on Assets
JNJ
LLY
MRK
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
LLY
Eli Lilly and CoSkjvd$752.8 Bil
MRK
Merck & Co IncHcv$314.2 Bil
ABBV
AbbVie IncRkrdk$312.8 Bil
RHHBY
Roche Holding AG ADRLjkvf$212.3 Bil
NVS
Novartis AG ADRVzxcc$208.6 Bil
AZN
AstraZeneca PLC ADRRvb$197.1 Bil
AMGN
Amgen IncYtf$149.7 Bil
PFE
Pfizer IncZkd$146.2 Bil
SNY
Sanofi SA ADRCgzh$117.5 Bil

Sponsor Center